Anhui Fulltime Specialized Solvent & Reagent

Anhui Fulltime Specialized Solvent & Reagent specializes in providing advanced technology solutions for operational efficiency and connectivity through innovative software platforms tailored for logistics, supply chain management, and customer relationship management. Anhui Fulltime Specialized Solvent & Reagent operates out of Anqing, China, focusing on technology solutions for a variety of industries. The company was founded with a clear mission to enhance operational efficiency in diverse sectors. There are no known changes in business strategy or operations.

The firm has completed a total of 1 deal, with the most recent deal occurring on September 12, 2013, when Sinopharm Capital invested an undisclosed amount in the company. Anhui Fulltime Specialized Solvent & Reagent specializes in advanced technology solutions aimed at enhancing operational efficiency across sectors. Their core products include innovative software platforms designed for logistics, supply chain management, and customer relationship management, catering to businesses in retail, manufacturing, and service industries. These solutions support real-time data analytics and integration capabilities, allowing clients to optimize workflows and improve customer engagement, primarily marketed in the Asia-Pacific region, particularly within China.

Anhui Fulltime Specialized Solvent & Reagent generates revenue through a combination of subscription-based services and direct sales. The firm engages in long-term partnerships with clients, offering tiered pricing plans to meet diverse business needs. Their flagship software platform is available via subscription, with options for monthly or annual billing, and they may facilitate B2B transactions through wholesale agreements with larger retail distributors, ensuring a steady revenue stream while providing flexibility for clients. Anhui Fulltime Specialized Solvent & Reagent plans to enhance its product offerings in the coming years, with new software platforms aimed at improving operational efficiencies expected to launch by late 2024.

The company is actively exploring expansion into Southeast Asian markets, targeting countries such as Vietnam and Thailand by 2025 to broaden its customer base. The investment from Sinopharm Capital in September 2013 will be utilized to support these growth initiatives, focusing on product development and market entry strategies.